Nicholas Investment Partners’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-116,229
| Closed | -$4.39M | – | 226 |
|
|
2025
Q1 | $4.39M | Buy |
116,229
+15,922
| +16% | +$601K | 0.45% | 92 |
|
|
2024
Q4 | $8.21M | Buy |
100,307
+18,424
| +23% | +$1.51M | 0.72% | 40 |
|
|
2024
Q3 | $9.36M | Sell |
81,883
-5,347
| -6% | -$611K | 0.86% | 33 |
|
|
2024
Q2 | $6.59M | Buy |
87,230
+1,586
| +2% | +$120K | 0.68% | 44 |
|
|
2024
Q1 | $5.85M | Sell |
85,644
-25,079
| -23% | -$1.71M | 0.6% | 56 |
|
|
2023
Q4 | $6.95M | Sell |
110,723
-349,285
| -76% | -$21.9M | 0.81% | 33 |
|
|
2023
Q3 | $23.5M | Sell |
460,008
-156
| -0% | -$7.95K | 1.75% | 16 |
|
|
2023
Q2 | $23M | Buy |
460,164
+26,364
| +6% | +$1.32M | 1.57% | 20 |
|
|
2023
Q1 | $16.3M | Buy |
433,800
+310,478
| +252% | +$11.6M | 1.24% | 29 |
|
|
2022
Q4 | $5.91M | Buy |
+123,322
| New | +$5.91M | 0.52% | 61 |
|